Our mission is 'Coding cells for novel cures'. bit.bio combines the concepts of coding and biology to provide human cells for research, drug discovery and cell therapy.
bit.bio is an award-winning human synthetic biology enterprise based in Cambridge, UK. bit.bio's mission is to code cells for health. Our breakthrough opti-ox technology platform is capable of producing consistent batches of every human cell. The technology directly reprograms stem cells into other human cell types with consistency at scale. Having access to human cells has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease and form the basis for a new generation of cell and tissue therapies.
Brands: Our portfolio of wild type and disease models ioCells includes: ioGlutamatergic Neurons, IoGlutamatergic Neurons HTT 50CAG/WT, IoGABAergic Neurons, ioSkeletal Myocytes.